Anzeige
Mehr »
Dienstag, 15.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
139 Leser
Artikel bewerten:
(0)

Argon Medical Devices, Inc.: Argon Medical Streamlines Distribution of Product and Enhances Customer Training for Europe, Asia, and Africa with the Debut of a Modern, Mixed-Use Facility

PLANO, Texas, July 15, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the grand opening of its new Distribution & Education Center (ADEC), strategically located in Derby, United Kingdom. This state-of-the-art facility represents a major step forward in the company's global operations, serving as a dedicated hub for over 80 countries across Europe, Africa, the Middle East (EMEA), and Asia-Pacific (APAC) regions.

Exterior photo of Argon Medical's new Distribution & Education Center (ADEC).

Spanning more than 20,000 square feet, ADEC combines a modern product distribution warehouse, corporate offices, and a specialized hands-on training area designed for physicians and distributors. This dedicated space enables immersive learning experiences on Argon's advanced product portfolio and procedural techniques.

This major investment underscores Argon Medical's commitment to enhancing customer service, operational excellence, and clinical support amid the rapid growth of the EMEA and APAC markets. By streamlining logistics and providing comprehensive education, the new facility is poised to accelerate product shipments, increase responsiveness, and foster stronger, more collaborative partnerships with regional stakeholders.

"Our foremost goal with ADEC is to deliver industry-leading operational support and clinical training to our teams and distributor partners across EMEA and APAC," said Matt Edwards, SVP, EMEA & APAC, Argon Medical. "This facility establishes a centralized hub for distribution, collaboration, and hands-on education. Equipped with a dedicated Clinical Education Center and cutting-edge digital capabilities, we are now able to offer both in-person and interactive online training at the highest standards."

George Leondis, President & CEO, Argon Medical remarked, "This new facility marks a significant milestone in our global growth strategy. By strengthening our presence in EMEA and APAC, we're not only expanding our operational footprint but also reinforcing our commitment to delivering innovative solutions and world-class support to customers across these regions."

A ribbon-cutting ceremony was held on July 15th in Derby, United Kingdom, marking the official opening of the new facility and the launch of the new capabilities it enables.

About Argon Medical

Since its founding in 1972, Argon Medical Devices has earned a reputation for delivering innovative products, superior service, and exceptional value for Interventional Radiologists, Vascular Surgeons, and Interventional Cardiologists worldwide. Argon is proud to have over 1,200 employees, and manufacture products in the United States in Texas, Illinois, New York, and Wisconsin. Argon brands are well-known globally, highlighted by the CLEANER Vac® Thrombectomy System, the Option ELITE IVC Filter, the Cleaner Rotational Thrombectomy System, the SuperCore Advantage® Semi-Automatic Biopsy Instrument, the BioPince Ultra Full-core Biopsy Instrument, and the SKATER Percutaneous Drainage Catheters. By utilizing a well-established sales and marketing infrastructure, Argon serves its global customers through a direct sales organization, and long-standing relationships with medical device distributors and strategic partners.

Interior photo of Argon Medical's new Distribution & Education Center (ADEC).

View of the new specialized hands-on training area of the facility.

View of the new distribution area of the facility.

Argon Medical Devices, Inc. Logo.

Photo - https://mma.prnewswire.com/media/2731295/Argon_1.jpg
Photo - https://mma.prnewswire.com/media/2731296/Argon_2.jpg
Photo - https://mma.prnewswire.com/media/2731297/Argon_3.jpg
Photo - https://mma.prnewswire.com/media/2731298/Argon_4.jpg
Logo - https://mma.prnewswire.com/media/319111/Argon_Medical1_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/argon-medical-streamlines-distribution-of-product-and-enhances-customer-training-for-europe-asia-and-africa-with-the-debut-of-a-modern-mixed-use-facility-302505345.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.